Protective effects of ginsenoside Rd against okadaic acid-induced neurotoxicity in vivo and in vitro. 2011

Ling Li, and Juanfang Liu, and Xiaodong Yan, and Kefeng Qin, and Ming Shi, and Tian Lin, and Yi Zhu, and Tao Kang, and Gang Zhao
Department of Neurology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

BACKGROUND Panax ginseng, a traditional Chinese herbal medicine, has been widely used to restore the disease and enhance the healthy body in Asia for about 5000 years. The present study aimed to investigate the possible neuroprotective effects of ginsenoside Rd against OA-induced toxicity. METHODS Ginsenoside Rd was used in tauopahy models of Alzheimer's disease (AD). To mimic the in vivo or in vitro tau hyperphosphorylation, okadaic acid (OA), a protein phosphatase inhibitor, was bilaterally micro-infused into the cerebral ventricle of adult male Sprague-Dawley (SD) rats, or added in media of cultured cortical neurons. The phosphorylation levels of tau and the activities of protein phosphatase 2A (PP-2A) were measured and compared with ginsenoside Rd pretreated groups. RESULTS Pretreatment with ginsenoside Rd in SD rats (10mg/kg for 7 days) or in cultured cortical neurons (2.5 or 5μmol/L for 12h) reduced OA-induced neurotoxicity and tau hyperphosphorylation by enhancing the activities of PP-2A. CONCLUSIONS The result of the present work implied that ginsenoside Rd protected SD rats and cultured cortical neurons against OA-induced toxicity. The possible neuroprotective mechanism may be that ginsenoside Rd decreases OA-induced the hyperphosphorylation of tau by the increase in activities of PP-2A. Thus, this study promises that ginsenoside Rd might be a potential preventive drug candidate for AD and other tau pathology-related neuronal degenerative diseases.

UI MeSH Term Description Entries
D008297 Male Males
D008517 Phytotherapy Use of plants or herbs to treat diseases or to alleviate pain. Herb Therapy,Herbal Therapy
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005894 Panax An araliaceous genus of plants that contains a number of pharmacologically active agents used as stimulants, sedatives, and tonics, especially in traditional medicine. Sometimes confused with Siberian ginseng (ELEUTHEROCOCCUS). Ginseng,Korean Ginseng,Korean Red Ginseng,Panax ginseng,Jen Shen,Ninjin,Renshen,Schinseng,Shinseng,Ginseng, Korean,Ginseng, Korean Red,Ginsengs,Jen Shens,Korean Ginsengs,Korean Red Ginsengs,Ninjins,Red Ginseng, Korean,Renshens,Schinsengs,Shen, Jen,Shinsengs
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Ling Li, and Juanfang Liu, and Xiaodong Yan, and Kefeng Qin, and Ming Shi, and Tian Lin, and Yi Zhu, and Tao Kang, and Gang Zhao
January 2015, Neurochemistry international,
Ling Li, and Juanfang Liu, and Xiaodong Yan, and Kefeng Qin, and Ming Shi, and Tian Lin, and Yi Zhu, and Tao Kang, and Gang Zhao
October 2008, Biological & pharmaceutical bulletin,
Ling Li, and Juanfang Liu, and Xiaodong Yan, and Kefeng Qin, and Ming Shi, and Tian Lin, and Yi Zhu, and Tao Kang, and Gang Zhao
March 2014, Cellular and molecular neurobiology,
Ling Li, and Juanfang Liu, and Xiaodong Yan, and Kefeng Qin, and Ming Shi, and Tian Lin, and Yi Zhu, and Tao Kang, and Gang Zhao
September 2007, Yao xue xue bao = Acta pharmaceutica Sinica,
Ling Li, and Juanfang Liu, and Xiaodong Yan, and Kefeng Qin, and Ming Shi, and Tian Lin, and Yi Zhu, and Tao Kang, and Gang Zhao
June 2018, Biological & pharmaceutical bulletin,
Ling Li, and Juanfang Liu, and Xiaodong Yan, and Kefeng Qin, and Ming Shi, and Tian Lin, and Yi Zhu, and Tao Kang, and Gang Zhao
January 2022, Toxicology,
Ling Li, and Juanfang Liu, and Xiaodong Yan, and Kefeng Qin, and Ming Shi, and Tian Lin, and Yi Zhu, and Tao Kang, and Gang Zhao
December 2019, Neurotoxicology,
Ling Li, and Juanfang Liu, and Xiaodong Yan, and Kefeng Qin, and Ming Shi, and Tian Lin, and Yi Zhu, and Tao Kang, and Gang Zhao
January 2018, Journal of Alzheimer's disease : JAD,
Ling Li, and Juanfang Liu, and Xiaodong Yan, and Kefeng Qin, and Ming Shi, and Tian Lin, and Yi Zhu, and Tao Kang, and Gang Zhao
July 2022, Toxics,
Ling Li, and Juanfang Liu, and Xiaodong Yan, and Kefeng Qin, and Ming Shi, and Tian Lin, and Yi Zhu, and Tao Kang, and Gang Zhao
January 2022, Nutrition and cancer,
Copied contents to your clipboard!